ADP/ATP translocase 2: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 02:53, 17 March 2025
ADP/ATP translocase 2 (also known as ANT2) is a protein that in humans is encoded by the SLC25A5 gene. This protein is a member of the mitochondrial carrier subfamily of solute carrier family 25.
Function[edit]
ADP/ATP translocase 2 is an integral membrane protein that catalyzes the exchange of adenosine diphosphate (ADP) and adenosine triphosphate (ATP) across the mitochondrial inner membrane. This exchange process is a critical step in mitochondrial respiration and cellular metabolism, as it allows ATP produced in the mitochondrial matrix to be transported into the cytosol where it can be used for energy-requiring processes, while simultaneously importing ADP into the matrix to be re-phosphorylated.
Structure[edit]
The ANT2 protein is composed of six transmembrane domains, with the N- and C-termini located in the cytoplasm. The transmembrane domains form a cavity in the center of the protein that allows for the passage of ADP and ATP.
Clinical significance[edit]
Mutations in the SLC25A5 gene have been associated with Amelogenesis imperfecta, a condition affecting the formation of enamel on teeth. Additionally, altered expression of ANT2 has been observed in several types of cancer, suggesting a potential role in tumor growth and survival.
See also[edit]
References[edit]
<references />
External links[edit]
- Human SLC25A5 gene details page in the National Center for Biotechnology Information (NCBI) database

This article is a membrane protein–related stub. You can help WikiMD by expanding it!
